retatrutide liver effects 12 mg resolved steatosis in more than 90% of patients with obesity, MASLD Triple hormone receptor agonist retatrutide

Per the applicant, the existing pass-through code C1747 (Endoscope, single-use ( i.e., disposable), urinary tract, imaging/illumination device (insertable)) does not appropriately describe the LithoVue TM Elite Ureteroscope because the category description does not include the LithoVue TM Elite Ureteroscope's pressure monitoring feature

As no comprehensive, clinically oriented summary of this topic currently exists, this review aims to outline the varied contexts in which such symptoms may co-occur and to highlight the clinical implications of making an accurate diagnosis

Section 1833(t)(8)(C)(ii) of the Act specifies that the Secretary must reduce the national unadjusted copayment amount for a covered OPD service (or group of such services) furnished in a year in a manner so that the effective copayment rate (determined on a national unadjusted basis) for that service in the year does not exceed a specified percentage

Olfatifar, M